CardioComm Solutions Inc. (EKG) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.215x

Based on the latest financial reports, CardioComm Solutions Inc. (EKG) has a cash flow conversion efficiency ratio of 0.215x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-121.85K ≈ $-88.15K USD) by net assets (CA$-567.74K ≈ $-410.69K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can CardioComm Solutions Inc. fund operations to measure how many days the company can operate on defensive assets alone.

CardioComm Solutions Inc. - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how CardioComm Solutions Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

CardioComm Solutions Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CardioComm Solutions Inc. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Epwin Group PLC
LSE:EPWN
0.139x
Starbreeze AB (publ)
ST:STAR-A
-0.015x
Fitell Corporation Ordinary Shares
NASDAQ:FTEL
-0.030x
EF EnergyFunders Ventures Inc
V:EFV
0.007x
Diadrom Holding AB
ST:DIAH
0.021x
Greenwave Technology Solutions Inc. Common Stock
NASDAQ:GWAV
-0.100x
PALATIN TECHS DL-01
F:PTN
N/A
CAP-EX IRON ORE
F:X0V
-0.025x

Annual Cash Flow Conversion Efficiency for CardioComm Solutions Inc. (2013–2024)

The table below shows the annual cash flow conversion efficiency of CardioComm Solutions Inc. from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see CardioComm Solutions Inc. stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CA$-276.58K
≈ $-200.07K
CA$-110.66K
≈ $-80.05K
0.400x +273.45%
2023-12-31 CA$-504.65K
≈ $-365.06K
CA$-54.07K
≈ $-39.11K
0.107x +180.05%
2022-12-31 CA$-407.32K
≈ $-294.65K
CA$54.52K
≈ $39.44K
-0.134x -146.91%
2021-12-31 CA$-423.38K
≈ $-306.26K
CA$-120.80K
≈ $-87.38K
0.285x +585.41%
2020-12-31 CA$-670.32K
≈ $-484.90K
CA$39.40K
≈ $28.50K
-0.059x -185.08%
2019-12-31 CA$-895.81K
≈ $-648.01K
CA$-61.89K
≈ $-44.77K
0.069x -97.55%
2018-12-31 CA$-68.41K
≈ $-49.49K
CA$-192.53K
≈ $-139.27K
2.814x +572.08%
2017-12-31 CA$489.32K
≈ $353.96K
CA$-291.70K
≈ $-211.01K
-0.596x -102.26%
2016-12-31 CA$-7.74K
≈ $-5.60K
CA$-204.16K
≈ $-147.68K
26.374x +6060.44%
2015-12-31 CA$-687.89K
≈ $-497.61K
CA$-294.50K
≈ $-213.03K
0.428x -44.88%
2014-12-31 CA$-595.83K
≈ $-431.02K
CA$-462.75K
≈ $-334.75K
0.777x -72.03%
2013-12-31 CA$-339.45K
≈ $-245.56K
CA$-942.44K
≈ $-681.75K
2.776x --

About CardioComm Solutions Inc.

V:EKG Canada Health Information Services
Market Cap
$2.14 Million
CA$2.96 Million CAD
Market Cap Rank
#29878 Global
#1503 in Canada
Share Price
CA$0.02
Change (1 day)
+50.00%
52-Week Range
CA$0.01 - CA$0.02
All Time High
CA$0.12
About

CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. The company offers consumer health monitoring products, including GEMS mobile ECG, GEMS mobile RPM, HeartCheck CardiBeat " Mobile ECG device, and HeartCheck SMAR… Read more